FDA Enforcement History: Ethicon Sarl, a Johnson & Johnson Company

FDA action counts

Enforcement history

On 2024-07-24, Argus HQ recorded an FDA recall for Ethicon Sarl, a Johnson & Johnson Company, rated "high" severity in Argus HQ's classification: Ethicon Sarl, a Johnson & Johnson Company — Class II recall: SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM), Product Number: 1961. On 2024-07-24, Argus HQ recorded an FDA recall for Ethicon Sarl, a Johnson & Johnson Company, rated "high" severity in Argus HQ's classification: Ethicon Sarl, a Johnson & Johnson Company — Class II recall: SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM), Product Number: 1963. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Ethicon Sarl, a Johnson & Johnson Company has 2 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event.

Frequently asked questions

What is the most recent FDA action against Ethicon Sarl, a Johnson & Johnson Company?

The most recent FDA event Argus HQ has on file for Ethicon Sarl, a Johnson & Johnson Company is dated 2024-07-24, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Ethicon Sarl, a Johnson & Johnson Company automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Ethicon Sarl, a Johnson & Johnson Company is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Ethicon Sarl, a Johnson & Johnson Company?

2 total: 0 warning letters, 2 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Ethicon Sarl, a Johnson & Johnson Company?

July 24, 2024. Argus HQ ingests new FDA enforcement records daily.

Related enforcement actions

• Ethicon Sarl, a Johnson & Johnson Company — Class II recall: SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM), Product Number: 1963 →
• Ethicon Sarl, a Johnson & Johnson Company — Class II recall: SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM), Product Number: 1961 →

Compare with

• Ethicon Sarl, a Johnson & Johnson Company vs Philips North America
• Ethicon Sarl, a Johnson & Johnson Company vs Boston Scientific Corporation
• Ethicon Sarl, a Johnson & Johnson Company vs Medline Industries, LP
• Ethicon Sarl, a Johnson & Johnson Company vs Baxter Healthcare Corporation
• Ethicon Sarl, a Johnson & Johnson Company vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.